Literature DB >> 12872846

Hypohomocysteinaemia and highly increased proportion of S-sulfonated plasma transthyretin in molybdenum cofactor deficiency.

J O Sass1, M Kishikawa, R Puttinger, J Reiss, W Erwa, A Shimizu, W Sperl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12872846     DOI： 10.1023/a:1024091900547

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  4 in total

1.  Human molybdopterin synthase gene: genomic structure and mutations in molybdenum cofactor deficiency type B.

Authors:  J Reiss; C Dorche; B Stallmeyer; R R Mendel; N Cohen; M T Zabot
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

2.  The peak height ratio of S-sulfonated transthyretin and other oxidized isoforms as a marker for molybdenum cofactor deficiency, measured by electrospray ionization mass spectrometry.

Authors:  Masahiko Kishikawa; Jörn Oliver Sass; Nobuo Sakura; Toyofumi Nakanishi; Akira Shimizu; Masanori Yoshioka
Journal:  Biochim Biophys Acta       Date:  2002-11-20

3.  Detection by mass spectrometry of highly increased amount of S-sulfonated transthyretin in serum from a patient with molybdenum cofactor deficiency.

Authors:  M Kishikawa; T Nakanishi; A Shimizu; M Yoshino
Journal:  Pediatr Res       Date:  2000-04       Impact factor: 3.756

4.  Ahomocysteinemia in molybdenum cofactor deficiency.

Authors:  W D Graf; O E Oleinik; R M Jack; A H Weiss; J L Johnson
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910
  4 in total
  1 in total

Review 1.  Homeostatic impact of sulfite and hydrogen sulfide on cysteine catabolism.

Authors:  Joshua B Kohl; Anna-Theresa Mellis; Guenter Schwarz
Journal:  Br J Pharmacol       Date:  2018-09-27       Impact factor: 8.739
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.